Melinta Therapeutics nets $67 mln
New Haven, Connecticut-based antibiotics developer Melinta Therapeutics has closed $67 million in funding. Malin Corporation plc led the round with participation from other investors that included Vatera Healthcare Partners.
10 June 2015•3 mins read
